Economic burden of atopic dermatitis in high-risk infants receiving cow's milk or partially hydrolyzed 100% whey-based formula

Journal of Pediatrics

Volumn 166, Issue 5, 2015, Pages 1145-1151.e3

  Bhanegaonkar, Abhijeet ^a   Horodniceanu, Erica G ^a   Ji, Xiang ^a   Detzel, Patrick ^b   Boguniewicz, Mark ^c   Chamlin, Sarah ^d   Lake, Alan ^e   Czerkies, Laura A ^b   Botteman, Marc F ^a   Saavedra, José M ^b,e  

^a PHARMERIT INTERNATIONAL   (United States)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c Children's Hospital Colorado   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; CORTICOSTEROID; EMOLLIENT AGENT; IMMUNOSUPPRESSIVE AGENT; NON PRESCRIPTION DRUG; MILK PROTEIN; WHEY PROTEIN;

ARTICLE; ARTIFICIAL MILK; ATOPIC DERMATITIS; BOTTLE FEEDING; CORTICOSTEROID THERAPY; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG COST; DRUG POTENCY; FOLLOW UP; HEALTH CARE COST; HIGH RISK INFANT; HUMAN; INFANT; MILK; NEWBORN; NUTRITIONAL REQUIREMENT; ONSET AGE; OUTCOME ASSESSMENT; PARTIALLY HYDROLYZED WHEY FORMULA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; TOPICAL TREATMENT; WHEY; ADVERSE EFFECTS; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; CHILD; COHORT ANALYSIS; COST BENEFIT ANALYSIS; COST OF ILLNESS; ECONOMICS; MILK HYPERSENSITIVITY; PRESCHOOL CHILD; PROBABILITY; RISK FACTOR; THEORETICAL MODEL; TREATMENT OUTCOME;

ANIMALS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DERMATITIS, ATOPIC; HUMANS; INFANT; INFANT FORMULA; INFANT, NEWBORN; MARKOV CHAINS; MILK; MILK HYPERSENSITIVITY; MILK PROTEINS; MODELS, THEORETICAL; RISK FACTORS; TREATMENT OUTCOME;

EID: 84928800137     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2015.02.017     Document Type: Article

References (43)

1. K.A. Horii, S.D. Simon, D.Y. Liu, and V. Sharma Atopic dermatitis in children in the United States, 1997-2004: visit trends, patient and provider characteristics, and prescribing patterns Pediatrics 120 2007 e527 e534
2. T.E. Shaw, G.P. Currie, C.W. Koudelka, and E.L. Simpson Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health J Invest Dermatol 131 2011 67 73
3. D. Laughter, J.A. Istvan, S.J. Tofte, and J.M. Hanifin The prevalence of atopic dermatitis in Oregon schoolchildren J Am Acad Dermatol 43 2000 649 655
4. R. Kapoor, C. Menon, O. Hoffstad, W. Bilker, P. Leclerc, and D.J. Margolis The prevalence of atopic triad in children with physician-confirmed atopic dermatitis J Am Acad Dermatol 58 2008 68 73
5. D. Fivenson, R.J. Arnold, D.J. Kaniecki, J.L. Cohen, F. Frech, and A.Y. Finlay The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization J Manag Care Pharm 8 2002 333 342
6. S.L. Chamlin, I.J. Frieden, M.L. Williams, and M.M. Chren Effects of atopic dermatitis on young American children and their families Pediatrics 114 2004 607 611
7. C.N. Ellis, L.A. Drake, M.M. Prendergast, W. Abramovits, M. Boguniewicz, and C.R. Daniel Cost of atopic dermatitis and eczema in the United States J Am Acad Dermatol 46 2002 361 370
8. A. von Berg, B. Filipiak-Pittroff, U. Kramer, B. Hoffmann, E. Link, and C. Beckmann Allergies in high-risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10-year results from the German Infant Nutritional Intervention (GINI) study J Allergy Clin Immunol 131 2013 1565 1573
9. D.D. Alexander, and M.D. Cabana Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta-analysis J Pediatr Gastroenterol Nutr 50 2010 422 430
10. H. Szajewska, and A. Horvath Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases Curr Med Res Opin 26 2010 423 437
11. A. Marini, M. Agosti, G. Motta, and F. Mosca Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow-up Acta Paediatr Suppl 414 1996 1 21
12. Y. Vandenplas, B. Hauser, C. Van den Borre, C. Clybouw, T. Mahler, and S. Hachimi-Idrissi The long-term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease Eur J Pediatr 154 1995 488 494
13. J.A. Boyce, A. Assa'ad, A.W. Burks, S.M. Jones, H.A. Sampson, and R.A. Wood Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel J Allergy Clin Immunol 126 2010 S1 S58
14. D.M. Fleischer, J.M. Spergel, A.H. Assa'ad, and J.A. Pongracic Primary prevention of allergic disease through nutritional interventions J Allergy Clin Immunol Pract 1 2013 29 36
15. A. Host, S. Halken, A. Muraro, S. Dreborg, B. Niggemann, and R. Aalberse Dietary prevention of allergic diseases in infants and small children Pediatr Allergy Immunol 19 2008 1 4
16. J. Mertens, S. Stock, M. Lungen, A. von Berg, U. Kramer, and B. Filipiak-Pittroff Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany Pediatr Allergy Immunol 23 2012 597 604
17. J. Su, S. Prescott, J. Sinn, M. Tang, P. Smith, and R.G. Heine Cost-effectiveness of partially-hydrolyzed formula for prevention of atopic dermatitis in Australia J Med Econ 15 2012 1064 1077
18. M. Iskedjian, C. Dupont, J. Spieldenner, G. Kanny, F. Raynaud, and B. Farah Economic evaluation of a 100% whey-based, partially hydrolysed formula in the prevention of atopic dermatitis among French children Curr Med Res Opin 26 2010 2607 2626
19. K.T. Park Perspectives on cost-effective medicine and the use of cost-effectiveness analyses J Pediatr Gastroenterol Nutr 54 2012 2 3
20. M.R. Gold Cost-effectiveness in health and medicine 1996 Oxford University Press New York (NY)
21. J.R. Beck, and S.G. Pauker The Markov process in medical prognosis Med Decis Making 3 1983 419 458
22. F.A. Sonnenberg, and J.R. Beck Markov models in medical decision making: a practical guide Med Decis Making 13 1993 322 338
23. A. von Berg, B. Filipiak-Pittroff, U. Kramer, E. Link, C. Bollrath, and I. Brockow Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI) J Allergy Clin Immunol 121 2008 1442 1447
24. A. von Berg, S. Koletzko, A. Grubl, B. Filipiak-Pittroff, H.E. Wichmann, and C.P. Bauer The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double-blind trial J Allergy Clin Immunol 111 2003 533 540
25. J.M. Saavedra, M. Boguniewicz, S. Chamlin, A. Lake, S. Nedorost, and L.A. Czerkies Patterns of clinical management of atopic dermatitis in infants and toddlers: a survey of three physician specialties in the United States J Pediatr 163 2013 1747 1753
26. World Bank data. United States mortality rate, under 5. http://www.google.com/publicdata/explore?ds=d5bncppjof8f9-&ctype=l&met-y=sh-dyn-mort&hl=en&dl=en#!ctype=l&strail=false&bcs=d&nselm=h&met-y=sh-dyn-mort&scale-y=lin&ind-y=false&rdim=region&idim=country:USA&ifdim=region&hl=en-US&dl=en&ind=false. Accessed October 25, 2013.
27. R.R. Briefel, L.M. Kalb, E. Condon, D.M. Deming, N.A. Clusen, and M.K. Fox The Feeding Infants and Toddlers Study 2008: study design and methods J Am Diet Assoc 110 2010 S16 S26
28. A.M. Siega-Riz, D.M. Deming, K.C. Reidy, M.K. Fox, E. Condon, and R.R. Briefel Food consumption patterns of infants and toddlers: where are we now? J Am Diet Assoc 110 2010 S38 S51
29. Micromedex 2.0, Red Book [database online]. Greenwood Village, CO: Truven Health Analytics, Inc. Updated periodically. http://www.micromedexsolutions.com/home/dispatch. Accessed June 6, 2013.
30. Medicaid-to-Medicare and Commercial-to-Medicare payment ratio for physician services rendered US population through age 21, by state, 2011 (based on 2012 AAP Pediatric Medical Cost Model). American Academy of Pediatrics Website. https://www.aap.org/en-us/professional-resources/practice-support/financing-and-payment/Documents/MedicareComparison.pdf. Accessed April 15, 2014.
31. Ingenix National Fee Analyzer 2013 2012 OptumInsight, Inc Salt Lake City (UT)
32. C. DeNavas-Walt, B.D. Proctor, and J.C. Smith Income, poverty, and health insurance coverage in the United States: 2012 US Census Bureau, Current Population Reports 2013 US Government Printing Office Washington, DC P60 P245
33. US Department of Labor, Bureau of Labor Statistics. Average hourly and weekly earnings of all employees on private nonfarm payrolls by industry sector, seasonally adjusted, June 2013. http://www.bls.gov/ces/tables.htm. Accessed January 5, 2015.
34. US Department of Labor, Bureau of Labor Statistics. Labor force statistics from the Current Population Survey: civilian labor force participation rate, age 16 years and over, seasonally adjusted, June 2013. http://data.bls.gov/timeseries/LNS11300000. Accessed January 4, 2015.
35. Centers for Disease Control and Prevention. Distance to nearest hospital files, NAMCS and NHAMCS (1999 to 2009). http://www.cdc.gov/nchs/data/ahcd/distance-to-nearest-hospital-file.pdf. Accessed January 5, 2015.
36. American Automobile Association Cost of owning and operating vehicle in US increases nearly two percent according to AAA's 2013 Your Driving Costs Study http://newsroom.aaa.com/2013/04/cost-of-owning-and-operating-vehicle-in-u-s-increases-nearly-two-percent-according-to-aaas-2013-your-driving-costs-study/ 2013 Accessed January 5, 2015
37. M. Iskedjian, H. Szajewska, J. Spieldenner, B. Farah, and J. Berbari Meta-analysis of a partially hydrolysed 100%-whey infant formula vs extensively hydrolysed infant formulas in the prevention of atopic dermatitis Curr Med Res Opin 26 2010 2599 2606
38. J. Chang, and J. Sung Health plan budget impact analysis for pimecrolimus J Manag Care Pharm 11 2005 66 73
39. R.R. Taylor, E. Sladkevicius, M. Panca, G. Lack, and J.F. Guest Cost-effectiveness of using an extensively hydrolysed formula compared to an amino acid formula as first-line treatment for cow milk allergy in the UK Pediatr Allergy Immunol 23 2012 240 249
40. B.E. Hamilton, J.A. Martin, and S.J. Ventura Births: preliminary data for 2012 Natl Vital Stat Rep 62 2013 1 20
41. A. von Berg, U. Kramer, E. Link, C. Bollrath, J. Heinrich, and I. Brockow Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course - the GINIplus study up to the age of 6 years Clin Exp Allergy 40 2010 627 636
42. P. Verboom, L. Hakkaart-Van, M. Sturkenboom, R. De Zeeuw, H. Menke, and F. Rutten The cost of atopic dermatitis in The Netherlands: an international comparison Br J Dermatol 147 2002 716 724
43. J.C. Su, A.S. Kemp, G.A. Varigos, and T.M. Nolan Atopic eczema: its impact on the family and financial cost Arch Dis Child 76 1997 159 162